• Calibre Investment Holdings, an associate of Ascendis Health director Theunis de Bruyn, has acquired 79,001 Ascendis Health shares in an on-market transaction.
• The purchase was made at a price of 62 cents per share, resulting in a total value of R48,980.62.
• The acquisition underscores confidence in Ascendis Health’s growth potential and aligns the interests of the director and Calibre Investment Holdings with the company’s strategic objectives.

In a move signaling confidence in Ascendis Health Limited’s future prospects, Calibre Investment Holdings (Pty) Ltd, an associate company of Ascendis Health director Theunis de Bruyn, has acquired a substantial number of the company’s shares. The transaction, carried out on May 12, 2023, involved the purchase of 79,001 Ascendis Health ordinary shares at a price of 62 cents per share, amounting to a total value of R48,980.62.

As per the disclosure made in compliance with the Listings Requirements of the JSE Limited, this on-market transaction underscores the belief in Ascendis Health’s growth potential by a closely associated entity. The director, Theunis de Bruyn, holds a position on the board of Ascendis Health and is also a shareholder of Calibre Investment Holdings, establishing an indirect and beneficial interest in this share acquisition.

The acquisition of Ascendis Health shares by Calibre Investment Holdings demonstrates the director’s confidence in the company’s long-term success. By aligning their interests with the company, both de Bruyn and Calibre Investment Holdings reaffirm their commitment to Ascendis Health’s strategic objectives.

Calibre Investment Holdings, whose directorship and shareholding are closely tied to Theunis de Bruyn, obtained the necessary clearance for this transaction in accordance with paragraph 3.66 of the JSE Limited Listings Requirements. This ensures compliance with the regulatory framework governing dealings of this nature.

Ascendis Health Limited, a prominent player in the healthcare industry, operates across multiple sectors, including pharmaceuticals, medical devices, and consumer health. The acquisition of a substantial number of shares by an associate of one of its directors reflects a continued belief in the company’s growth potential and future value.

It is important to note that this announcement serves as a reminder of the ongoing commitment of Ascendis Health and its associated entities to achieve strategic objectives and enhance shareholder value. The acquisition of additional shares by Calibre Investment Holdings further aligns the interests of Theunis de Bruyn and the company, reinforcing their support for Ascendis Health’s future endeavors.

Investors and industry observers will be keen to monitor how this share acquisition by Calibre Investment Holdings, facilitated by its association with Ascendis Health director Theunis de Bruyn, may impact the company’s trajectory in the coming months.